Initially, withholding GLP-1 RAs was advised for in-hospital patients, whereas others are considering perioperative continuation, given the low risk of hypoglycaemia and improved glycaemic control,14,16,17 also because the advent of longer-acting (once-weekly) preparations makes adequate withholding more impractical.18 This evidence concerns the gene GCG and Hypoglycemia.